Back to search

University of Sheffield

VEGFA isoform expression and its regulation of the Tumour Microenvironment in Soft Tissue Sarcoma

Abstract

dc:description.abstract

Soft Tissue Sarcomas (STS) are a heterogeneous group of tumours of mesenchymal origin. Their diagnosis is challenging; few new treatments have become available. As a result, novel treatments are needed. Targeting angiogenic pathways and immune regulatory mechanisms within the tumour microenvironment (TME) might provide promising results. Published studies have shown that fibrosarcomas expressing VEGFA120 (fsVEGFA120) isoform in mice led to formation of poorly functioning vasculature and increased metastasis to the lung that was more sensitive to anti-VEGFA therapy in contrast to fsVEGFA18. Unpublished analysis of RNAseq data from these fsVEGFA120 revealed expression enrichment in PD-1 signalling and PD-L1. Further bioinformatics analysis from The Cancer Genome Atlas-SARComa in our laboratory revealed decrease overall survival and increased expression of PD-L1 signalling pathways in myxofibrosarcoma (MFS) patients with increased VEGFA121 mRNA. This PhD thesis aimed to build on these preliminary studies additional evidence of VEGFA isoform measurement as a potential biomarker for the use of anti-VEGFA and immune checkpoint inhibitors in MFS. Previous studies used immunocompromised mice; thus, new models of sarcoma are needed in immunocompetent mice. Firstly, this thesis characterised the TME of tumours grown from the T241 fibrosarcoma cell line in C57Bl6J mice. Then new cell lines were made from T241 cells that expressed increased levels of VEGFA120 or VEGFA188. Both cell lines were characterised in vitro, with only VEGFA188 being characterised in vivo using immunocompetent mice due to time constraints. In vitro characterisations showed differences between cells lines overexpressing the different VEGFA isoforms, including morphology, migration speed, ECM expression, and mesenchymal markers suggesting isoform expression can regulate the TME. In vivo characterisation of VEGFA188 tumours showed a tendency to regression after initial growth, which might suggest increased anti-tumoural immune cells activity. VEGFA188 tumours had a more mature vasculature and similar or lower immune cell infiltrations compared to WT tumours. A new data set was created by combining the VORTEX and TCGA SARC data to increase pleomorphic patient numbers. Analysis of this new dataset showed patients with high VEGFA121 expression had enriched expression of host-immune response genes and PD-1 signalling. Our findings indicate that VEGFA isoform expression is associated with changes that may be advantageous for an improved therapeutic response in MFS patients.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Madrigal Esquivel, Claudia
Advisors dc:contributor.advisor
  • English, William
  • Wang, Dennis
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.888174

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Madrigal Esquivel, Claudia. VEGFA isoform expression and its regulation of the Tumour Microenvironment in Soft Tissue Sarcoma. doctoral thesis, University of Sheffield, 2022.